+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Biopolymers for Medical Applications Market by Type (Bio-Based Polyethylene, Bio-degradable Starch Blends, Bio-PC), Source (Natural, Synthetic), Application - Forecast 2023-2030

  • PDF Icon

    Report

  • 184 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829857
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biopolymers for Medical Applications Market size was estimated at USD 1.98 billion in 2022, USD 2.43 billion in 2023, and is expected to grow at a CAGR of 23.22% to reach USD 10.52 billion by 2030.

Biopolymer market for medical applications is experiencing significant growth owing to the ever-evolving demands of the modern healthcare industry. These natural or biologically synthesized polymers are essential in the creation of cutting-edge medical tools and devices, including biodegradable stents, drug delivery systems, and sutures, all admired for their compatibility with the human body, natural decomposition, and reduced toxicity. Their applications are diverse, spanning regenerative medicine, pharmaceuticals, and surgical procedures. Market expansion is fueled by the surging need for biocompatible materials, groundbreaking technological progression in biopolymers, and a rising prevalence of chronic diseases. The market teems with opportunities, promising advances in production efficiency and novel biopolymers featuring smart functional properties such as stimuli-responsiveness. Nevertheless, the industry faces certain constraints, including the steep costs of research and development, stringent regulatory landscapes, and stiff competition from synthetic polymers. Undoubtedly, innovation and research are pivotal, focusing on developing tailored biopolymers for specific medical needs and optimizing performance to align with clinical applications. Additionally, exploring sustainable production methods and forging strong relationships with healthcare entities will be instrumental in advancing this exciting field.

Regional Insights

The United States is at the forefront in the consumption and innovation of biopolymers for medical applications due to its robust medical infrastructure. The demand is driven by advanced healthcare facilities, a growing elderly population, and a strong focus on sustainable materials. Canadian efforts align with those of the US, emphasizing ecological impact and the integration of biopolymers in advanced wound care and orthopedics. In terms of latest patents, research and investment, North America is a productive ground for innovation in biopolymer technology. EU countries exhibit a robust commitment to reducing environmental impact, which translates to active support for biopolymer applications in the medical sector. Much of the demand is influenced by the region's strong regulatory framework for medical devices and materials, particularly those that are eco-friendly and sustainable. Recent investments in the EU are funneled into research institutions focusing on biopolymers, and institutions such as the European Patent Office showcase a steady stream of new patents, indicating a dynamic innovation landscape. In Asia Pacific's biopolymer market, China, Japan, and India are prominent players. The region presents a diverse market with consumer needs varying from affordable healthcare solutions in India to advanced medical technologies in Japan.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopolymers for Medical Applications Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopolymers for Medical Applications Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopolymers for Medical Applications Market, highlighting leading vendors and their innovative profiles. These include BASF SE, Biesterfeld AG, BioPolymer GmbH & Co. KG, Blafar Ltd., Corbion NV, Danimer Scientific, Inc., DuPont de Nemours, Inc., Eastman Chemical Company, Evonik Industries AG, Geistlich Pharma AG, GELITA AG, Green Dot Bioplastics Inc., HTL, HyMedPoly, Invibio Ltd. by Victrex PLC, ITV Denkendorf Product Service GmbH, Merck & Co., Inc., NatureWorks LLC, Rodenburg Productie B.V., Solvay S.A., SolyPlus GmbH, Symatese, Tate & Lyle PLC, Thermo Fisher Scientific, Inc., and Toray Industries Inc.

Market Segmentation & Coverage

This research report categorizes the Biopolymers for Medical Applications Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Bio-Based Polyethylene
    • Bio-degradable Starch Blends
    • Bio-PC
    • Bio-PET
    • Bio-PUR
    • Cellulose Derivatives
    • PHA
    • Regenerated Cellulose
  • Source
    • Natural
    • Synthetic
  • Application
    • Bioresorbable Scaffolds
    • Dentistry
    • Drug Delivery Systems.
    • Healing Products
    • Surgical Implant Devices
    • Therapeutic Imaging
    • Wound Closure
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Biopolymers for Medical Applications Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopolymers for Medical Applications Market?
  3. What are the technology trends and regulatory frameworks in the Biopolymers for Medical Applications Market?
  4. What is the market share of the leading vendors in the Biopolymers for Medical Applications Market?
  5. Which modes and strategic moves are suitable for entering the Biopolymers for Medical Applications Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biopolymers for Medical Applications Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Biopolymers demand for Manufacturing of Medical Devices and Implants
5.1.1.2. Growing Adoption of Biopolymers for Advanced Imaging and Skeletal Tissue-Specific Therapeutics
5.1.1.3. Development of Sterilization Technology for Biopolymers
5.1.2. Restraints
5.1.2.1. Performance Issues Associated with the Biopolymers
5.1.3. Opportunities
5.1.3.1. Innovations and Sustainable Production of Biopolymers
5.1.3.2. Proliferation of Nano-Particle Drug Delivery Systems in Cancer
5.1.4. Challenges
5.1.4.1. Biocompatibility Issues Associated with Synthetic Biopolymers
5.2. Market Segmentation Analysis
5.2.1. Type: Rising inclination toward the sustainability is emphasizing focus on application of biopolymers healthcare
5.2.2. Source: Synthetic biopolymers are in demand due to enhanced biocompatibility, biofunctionality, mechanical properties, degradation rates, and immunogenicity
5.2.3. Application: Expandable use in drug discovery, and wound closure owing to the rising tissue generation capability
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
5.10.1. Patent Analysis & Trend
6. Biopolymers for Medical Applications Market, by Type
6.1. Introduction
6.2. Bio-Based Polyethylene
6.3. Bio-degradable Starch Blends
6.4. Bio-PC
6.5. Bio-PET
6.6. Bio-PUR
6.7. Cellulose Derivatives
6.8. PHA
6.9. Regenerated Cellulose
7. Biopolymers for Medical Applications Market, by Source
7.1. Introduction
7.2. Natural
7.3. Synthetic
8. Biopolymers for Medical Applications Market, by Application
8.1. Introduction
8.2. Bioresorbable Scaffolds
8.3. Dentistry
8.4. Drug Delivery Systems.
8.5. Healing Products
8.6. Surgical Implant Devices
8.7. Therapeutic Imaging
8.8. Wound Closure
9. Americas Biopolymers for Medical Applications Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biopolymers for Medical Applications Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Biopolymers for Medical Applications Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. DuPont Completes Acquisition of Spectrum Plastics Group
12.3.1.2. Sanofi completes acquisition of Provention Bio, Inc.
12.3.2. Award, Recognition, & Expansion
12.3.2.1. Victrex Invests In New Medical Device Product Development Centre And Manufacturing Expansion
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. BASF SE
13.1.2. Biesterfeld AG
13.1.3. BioPolymer GmbH & Co. KG
13.1.4. Blafar Ltd.
13.1.5. Corbion NV
13.1.6. Danimer Scientific, Inc.
13.1.7. DuPont de Nemours, Inc.
13.1.8. Eastman Chemical Company
13.1.9. Evonik Industries AG
13.1.10. Geistlich Pharma AG
13.1.11. GELITA AG
13.1.12. Green Dot Bioplastics Inc.
13.1.13. HTL
13.1.14. HyMedPoly
13.1.15. Invibio Ltd. by Victrex PLC
13.1.16. ITV Denkendorf Product Service GmbH
13.1.17. Merck & Co., Inc.
13.1.18. NatureWorks LLC
13.1.19. Rodenburg Productie B.V.
13.1.20. Solvay S.A.
13.1.21. SolyPlus GmbH
13.1.22. Symatese
13.1.23. Tate & Lyle PLC
13.1.24. Thermo Fisher Scientific, Inc.
13.1.25. Toray Industries Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET RESEARCH PROCESS
FIGURE 2. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2022 VS 2030
FIGURE 3. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET DYNAMICS
FIGURE 7. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
FIGURE 10. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • BASF SE
  • Biesterfeld AG
  • BioPolymer GmbH & Co. KG
  • Blafar Ltd.
  • Corbion NV
  • Danimer Scientific, Inc.
  • DuPont de Nemours, Inc.
  • Eastman Chemical Company
  • Evonik Industries AG
  • Geistlich Pharma AG
  • GELITA AG
  • Green Dot Bioplastics Inc.
  • HTL
  • HyMedPoly
  • Invibio Ltd. by Victrex PLC
  • ITV Denkendorf Product Service GmbH
  • Merck & Co., Inc.
  • NatureWorks LLC
  • Rodenburg Productie B.V.
  • Solvay S.A.
  • SolyPlus GmbH
  • Symatese
  • Tate & Lyle PLC
  • Thermo Fisher Scientific, Inc.
  • Toray Industries Inc.

Methodology

Loading
LOADING...

Table Information